Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 780

1.

Early diagnosis of Alzheimer's disease using cortical thickness: impact of cognitive reserve.

Querbes O, Aubry F, Pariente J, Lotterie JA, Démonet JF, Duret V, Puel M, Berry I, Fort JC, Celsis P; Alzheimer's Disease Neuroimaging Initiative.

Brain. 2009 Aug;132(Pt 8):2036-47. doi: 10.1093/brain/awp105. Epub 2009 May 12.

2.

Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease.

Desikan RS, Cabral HJ, Hess CP, Dillon WP, Glastonbury CM, Weiner MW, Schmansky NJ, Greve DN, Salat DH, Buckner RL, Fischl B; Alzheimer's Disease Neuroimaging Initiative.

Brain. 2009 Aug;132(Pt 8):2048-57. doi: 10.1093/brain/awp123. Epub 2009 May 21.

3.

Longitudinal brain metabolic changes from amnestic mild cognitive impairment to Alzheimer's disease.

Fouquet M, Desgranges B, Landeau B, Duchesnay E, Mézenge F, de la Sayette V, Viader F, Baron JC, Eustache F, Chételat G.

Brain. 2009 Aug;132(Pt 8):2058-67. doi: 10.1093/brain/awp132. Epub 2009 May 28.

4.

Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort.

Risacher SL, Saykin AJ, West JD, Shen L, Firpi HA, McDonald BC; Alzheimer's Disease Neuroimaging Initiative (ADNI).

Curr Alzheimer Res. 2009 Aug;6(4):347-61.

5.

Analysis of regional MRI volumes and thicknesses as predictors of conversion from mild cognitive impairment to Alzheimer's disease.

Liu Y, Paajanen T, Zhang Y, Westman E, Wahlund LO, Simmons A, Tunnard C, Sobow T, Mecocci P, Tsolaki M, Vellas B, Muehlboeck S, Evans A, Spenger C, Lovestone S, Soininen H; AddNeuroMed Consortium.

Neurobiol Aging. 2010 Aug;31(8):1375-85. doi: 10.1016/j.neurobiolaging.2010.01.022. Epub 2010 May 5.

PMID:
20447732
6.

Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative.

Gomar JJ, Bobes-Bascaran MT, Conejero-Goldberg C, Davies P, Goldberg TE; Alzheimer's Disease Neuroimaging Initiative.

Arch Gen Psychiatry. 2011 Sep;68(9):961-9. doi: 10.1001/archgenpsychiatry.2011.96.

PMID:
21893661
7.

Cortical thickness analysis to detect progressive mild cognitive impairment: a reference to Alzheimer's disease.

Julkunen V, Niskanen E, Muehlboeck S, Pihlajamäki M, Könönen M, Hallikainen M, Kivipelto M, Tervo S, Vanninen R, Evans A, Soininen H.

Dement Geriatr Cogn Disord. 2009;28(5):404-12. doi: 10.1159/000256274. Epub 2009 Nov 10.

8.

Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease.

Jack CR Jr, Wiste HJ, Vemuri P, Weigand SD, Senjem ML, Zeng G, Bernstein MA, Gunter JL, Pankratz VS, Aisen PS, Weiner MW, Petersen RC, Shaw LM, Trojanowski JQ, Knopman DS; Alzheimer's Disease Neuroimaging Initiative.

Brain. 2010 Nov;133(11):3336-48. doi: 10.1093/brain/awq277. Epub 2010 Oct 8.

9.

Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment.

Fleisher AS, Sun S, Taylor C, Ward CP, Gamst AC, Petersen RC, Jack CR Jr, Aisen PS, Thal LJ.

Neurology. 2008 Jan 15;70(3):191-9. doi: 10.1212/01.wnl.0000287091.57376.65.

PMID:
18195264
10.

Cortical changes in incipient Alzheimer's disease.

Prestia A, Drago V, Rasser PE, Bonetti M, Thompson PM, Frisoni GB.

J Alzheimers Dis. 2010;22(4):1339-49. doi: 10.3233/JAD-2010-101191.

PMID:
20930288
11.

Spatial patterns of cortical thinning in mild cognitive impairment and Alzheimer's disease.

Singh V, Chertkow H, Lerch JP, Evans AC, Dorr AE, Kabani NJ.

Brain. 2006 Nov;129(Pt 11):2885-93. Epub 2006 Sep 28.

12.

Volumetric and visual rating of magnetic resonance imaging scans in the diagnosis of amnestic mild cognitive impairment and Alzheimer's disease.

Shen Q, Loewenstein DA, Potter E, Zhao W, Appel J, Greig MT, Raj A, Acevedo A, Schofield E, Barker W, Wu Y, Potter H, Duara R.

Alzheimers Dement. 2011 Jul;7(4):e101-8. doi: 10.1016/j.jalz.2010.07.002.

13.

Differences in cortical thickness in healthy controls, subjects with mild cognitive impairment, and Alzheimer's disease patients: a longitudinal study.

Julkunen V, Niskanen E, Koikkalainen J, Herukka SK, Pihlajamäki M, Hallikainen M, Kivipelto M, Muehlboeck S, Evans AC, Vanninen R, Hilkka Soininen.

J Alzheimers Dis. 2010;21(4):1141-51.

PMID:
21504134
14.

Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.

Portelius E, Zetterberg H, Skillbäck T, Törnqvist U, Andreasson U, Trojanowski JQ, Weiner MW, Shaw LM, Mattsson N, Blennow K; Alzheimer’s Disease Neuroimaging Initiative.

Brain. 2015 Nov;138(Pt 11):3373-85. doi: 10.1093/brain/awv267. Epub 2015 Sep 15.

PMID:
26373605
15.

Regional magnetic resonance imaging measures for multivariate analysis in Alzheimer's disease and mild cognitive impairment.

Westman E, Aguilar C, Muehlboeck JS, Simmons A.

Brain Topogr. 2013 Jan;26(1):9-23. doi: 10.1007/s10548-012-0246-x. Epub 2012 Aug 14.

16.

Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study.

Drzezga A, Lautenschlager N, Siebner H, Riemenschneider M, Willoch F, Minoshima S, Schwaiger M, Kurz A.

Eur J Nucl Med Mol Imaging. 2003 Aug;30(8):1104-13. Epub 2003 May 23.

PMID:
12764551
17.

Cognitive reserve and Alzheimer's disease biomarkers are independent determinants of cognition.

Vemuri P, Weigand SD, Przybelski SA, Knopman DS, Smith GE, Trojanowski JQ, Shaw LM, Decarli CS, Carmichael O, Bernstein MA, Aisen PS, Weiner M, Petersen RC, Jack CR Jr; Alzheimer's Disease Neuroimaging Initiative.

Brain. 2011 May;134(Pt 5):1479-92. doi: 10.1093/brain/awr049. Epub 2011 Apr 7.

18.

3D comparison of hippocampal atrophy in amnestic mild cognitive impairment and Alzheimer's disease.

Apostolova LG, Dinov ID, Dutton RA, Hayashi KM, Toga AW, Cummings JL, Thompson PM.

Brain. 2006 Nov;129(Pt 11):2867-73. Epub 2006 Oct 3. Erratum in: Brain. 2007 Sep;130(Pt 9):2474.

19.

Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.

Villain N, Chételat G, Grassiot B, Bourgeat P, Jones G, Ellis KA, Ames D, Martins RN, Eustache F, Salvado O, Masters CL, Rowe CC, Villemagne VL; AIBL Research Group.

Brain. 2012 Jul;135(Pt 7):2126-39. doi: 10.1093/brain/aws125. Epub 2012 May 23.

20.

MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment.

Whitwell JL, Shiung MM, Przybelski SA, Weigand SD, Knopman DS, Boeve BF, Petersen RC, Jack CR Jr.

Neurology. 2008 Feb 12;70(7):512-20. Epub 2007 Sep 26.

Items per page

Supplemental Content

Write to the Help Desk